Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant.

Victor EuzenAliénor XhaardSamar Berreira-IbraimLaure DevilleAude QuentinPedro Hendrique De Lima PrataViviane GournayMatthieu ProtYannis RahouMarion BarbetSéverine Mercier-DelarueRégis Peffault De La TourEtienne Simon-LoriereJérôme Legoff

Published in: International journal of antimicrobial agents (2024)

These observations underscore the importance of further investigating combination treatments as the primary approach to achieve influenza eradication in immunocompromised patients.

Keyphrases

hematopoietic stem cell
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
prognostic factors
peritoneal dialysis
helicobacter pylori infection
patient reported outcomes
patient reported
respiratory failure